Scarica l'app Stockscreener
12.65
2.76%
0.34
Dopo l'orario di chiusura:
12.61
-0.04
-0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABCL Giù?
Forum
Previsione
Abcellera Biologics Inc Borsa (ABCL) Ultime notizie
ABCL Reinstated by Goldman Sachs -- Neutral Rating with Price Ta - GuruFocus
Goldman Sachs resumes AbCellera stock coverage with neutral rating By Investing.com - Investing.com Canada
ABCL Looks 201.0% Overvalued on GF Value™ - GuruFocus
AbCellera Biologics Inc. (ABCL) Options Chain - Yahoo Finance
ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know - Yahoo Finance
ABCL Should I Buy - Intellectia AI
AbCellera Biologics Inc. (ABCL) Stock Analysis: A Biotech Gem With A 34% Upside Potential - DirectorsTalk Interviews
Biotech Stocks At 52-Week HighsMNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews
Abcellera Biologics stock hits 52-week high at 12.58 USD By Investing.com - Investing.com Australia
Abcellera Biologics stock hits 52-week high at 12.58 USD - Investing.com
Abcellera Biologics Inc (ABCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AbCellera to present phase 2 data on menopause treatment drug By Investing.com - Investing.com Nigeria
ABCL Looks 171.0% Overvalued on GF Value™ - GuruFocus
AbCellera to present phase 2 data on menopause treatment drug - Investing.com
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026 - Business Wire
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week? - Stocktwits
AbCellera at Cantor healthcare conference: nk3r drug boosts hopes By Investing.com - Investing.com South Africa
AbCellera at Cantor healthcare conference: nk3r drug boosts hopes - Investing.com
AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026 - Investing News Network
symbol__ Stock Quote Price and Forecast - CNN
ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill
Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $30 - Moomoo
AbCellera Biologics (ABCL) Q4 2025 Earnings: Results, Market Reaction & History - 24/7 Wall St.
AbCellera Biologics Stock (ABCL) Opinions on Recent Surge and Insider Buying - Quiver Quantitative
Historical Data for AbCellera Biologics Inc. Tokenized Stock (Robinhood) in USD - CryptoRank
What'sGoing On With AbCellera Biologics Stock On Tuesday? - Benzinga
ABCL Stock Surges As ABCL635 Data Reprices Hot-Flash Market - timothysykes.com
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - Eastern Progress
ABCL StockAbCellera Biologics Inc Stock Breaking News Today | ABCL Stock Price Punaises (dD09m2oJ3D) - Mshale
AbCellera Biologics (ABCL) Reports Phase 2 Success, Is It Still A Bargain? - simplywall.st
Abcellera director John S. Montalbano acquires common shares worth $110,300 - Bitget
AbCellera Biologics Director John S. Montalbano Acquires 10,000 Shares on August 18, 2026 - Kalkine Media
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Montalbano John S. - Moomoo
BMO Capital Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $15 - Moomoo
AbCellera (ABCL) Q2 2026 Earnings Call Transcript - AOL.com
Abcellera Biologics stock hits 52-week high at 11.51 USD - Investing.com
Abcellera Biologics stock hits 52-week high at 11.51 USD By Investing.com - Investing.com India
Why AbCellera (ABCL) Is Up 64.2% After Menopause Trial Win, Equity Raise And Vertex Deal - simplywall.st
AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity - Yahoo Finance
AbCellera Biologics Stock (ABCL) Opinions on Positive Phase 2 Trial Results - Quiver Quantitative
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough? - Yahoo Finance
AbCellera Biologics Inc. • Robinhood Token (ABCL) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
AbCellera CFO Andrew Booth Acquires 37,200 Shares at $10.32 Each - Kalkine Media
AbCellera Biologics Director Michael R. Hayden Acquires 46,387 Shares at $10.37 Average Price - Kalkine Media
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Booth Andrew - Moomoo
AbCellera Biologics Stock 6-Day Winning Spree: Stock Climbs 85% - Trefis
6 Green Days In A Row: AbCellera Biologics Stock Is Up 85% - Trefis
AbCellera Biologics (ABCL) Slips 2.32% to $10.71 as Biotech Sentiment CoolsMcClellan Summation - careplusvn.com
AbCellera prices US $200M offering at US $9.75 a share - Private Capital Journal
AbCellera Biologics | 424B5: Prospectus - Moomoo
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Hayden Michael R - Moomoo
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session - Sahm
AbCellera Director Michael R. Hayden Donates 50,000 Shares to Charity via Genworks 2 Consulting - Kalkine Media
1.11%
1.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):